Silica-Assisted Solid-Phase Peptide Synthesis (SiPPS)

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Materials Science

Background:

• Solid-phase peptide synthesis (SPPS) is a cornerstone of peptide production.
• Traditional SPPS often relies on swelling resins, leading to significant solvent consumption.
• Developing alternative supports and strategies is crucial for sustainable chemical synthesis.

Purpose of the Study:

• To introduce and evaluate a novel silica-assisted solid-phase peptide synthesis (SiPPS) strategy.
• To demonstrate the efficacy of a non-swelling, silica-based resin for peptide synthesis.
• To assess the impact of SiPPS on solvent consumption and peptide purity.

Main Methods:

• Utilized a non-swelling, silica-based resin (Fmoc-Rink amide SiliaBond) for peptide synthesis.
• Adapted the standard solid-phase peptide synthesis (SPPS) protocol for the silica support.
• Investigated the effect of extended coupling times (2-h vs. 1-h) on reaction efficiency.
• Synthesized model peptides including H-YSSFL-NH2, linear oxytocin, angiotensin II, and afamelanotide.

Main Results:

• The silica-assisted solid-phase peptide synthesis (SiPPS) strategy was successfully demonstrated for multiple peptide targets.
• A 2-hour coupling step showed improved efficiency compared to the standard 1-hour coupling.
• The non-swelling nature of the silica resin resulted in a 50% reduction in solvent consumption.
• Synthesized peptides exhibited acceptable purity, though overall yields were slightly reduced.

Conclusions:

• Silica-assisted solid-phase peptide synthesis (SiPPS) presents a viable and greener alternative to conventional SPPS.
• The use of non-swelling silica-based resins significantly reduces solvent waste.
• Further optimization may be needed to improve overall yields while maintaining purity and sustainability.